Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,300 JPY | -1.15% |
|
-.--% | +8.18% |
06-24 | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
06-24 | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |